| dc.creator | Lopes-Cendes I. | |
| dc.creator | Guerreiro C.A.M. | |
| dc.date | 2011 | |
| dc.date | 2015-06-30T20:25:10Z | |
| dc.date | 2015-11-26T14:49:12Z | |
| dc.date | 2015-06-30T20:25:10Z | |
| dc.date | 2015-11-26T14:49:12Z | |
| dc.date.accessioned | 2018-03-28T22:00:08Z | |
| dc.date.available | 2018-03-28T22:00:08Z | |
| dc.identifier | | |
| dc.identifier | Arquivos De Neuro-psiquiatria. , v. 69, n. 02:00:00, p. 151 - 152, 2011. | |
| dc.identifier | 0004282X | |
| dc.identifier | | |
| dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-79955768789&partnerID=40&md5=c0aa2318690d4181fa17a9b2ba1244fb | |
| dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/107858 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/107858 | |
| dc.identifier | 2-s2.0-79955768789 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1253828 | |
| dc.description | [No abstract available] | |
| dc.description | 69 | |
| dc.description | 02:00:00 | |
| dc.description | 151 | |
| dc.description | 152 | |
| dc.description | Twardowschy, C.A., Werneck, L.C., Scola, R.H., Depaola, L., Silvado, C.E., CYP2C9 polymorphisms in patients with epilepsy. Genotypic frequency analyzes and phe-nytoin adverse reactions correlations (2011) Arq Neurop-siquiatr, 69, pp. 153-158 | |
| dc.description | Glauser, T., Bem-Menachen, E., Bourgeois, B., ILAE treatment guidelines: Evidence-based analysis of an-tiepileptic drug efcacy and efectiveness as initialmonotherapy for epileptic seizures and syndromes (2006) Epilepsia, 47, pp. 1094-1120 | |
| dc.description | Gidal, B.E., French, J.A., Grossman, P., le Teuf, G., Assessment of potential drug interactions in patients with epilepsy:Impact of age and sex (2009) Neurology, 72, pp. 419-425 | |
| dc.description | Vogel, F., Moderne probleme der humangenetik (1959) Ergeb Inn Med Kinder-heilkd, 12, pp. 52-125 | |
| dc.description | Johnson, J.A., Pharmacogenetics: Potential for individualized drug therapy through genetics (2003) Trends Genet, 19, pp. 660-666 | |
| dc.description | Initial sequencing and analysis of the human genome (2001) Nature, 409, pp. 860-921. , International Human Genome Sequence Consortium | |
| dc.description | Jordan, D.M., Ramensky, V.E., Sunyaev, S.R., Human allelic variation: Perspective from protein function, structure, and evolution (2010) Curr Opin Struct Biol, 20, pp. 342-350 | |
| dc.description | Evans, B.J., Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era (2010) Clin Pharmacol Ther, 88, pp. 749-751 | |
| dc.description | Hamburg, M.A., Collins, F.S., The path to personalized medicine (2010) N Engl J Med, 363, pp. 301-304 | |
| dc.description | (2009) Carbamazepine (market As Car-batrol, Equetro, Tegretol and Generics), , http:www.fda.gov/cder/drug/InfoSheet/HCP/carba-mazepineHCP.htm, Information for healthcare professionals, FDA Alert 12/12/07, updated 1/31/08 | |
| dc.language | en | |
| dc.publisher | | |
| dc.relation | Arquivos de Neuro-Psiquiatria | |
| dc.rights | aberto | |
| dc.source | Scopus | |
| dc.title | Pharmacogenetics Reality Or Fction? Or Are We There Yet? | |
| dc.type | Artículos de revistas | |
